DEFA14A 1 tmb-20210428xdefa14a.htm DEFA14A



Washington, D.C. 20549


Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

(Amendment No. ___)

Filed by the Registrant                              Filed by a party other than the Registrant

Check the appropriate box: 

   Preliminary Proxy Statement

   Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

   Definitive Proxy Statement

   Definitive Additional Materials

   Soliciting Material under §240.14a-12

Aprea Therapeutics, Inc.

(Name of Registrant as Specified in Its Charter)

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box): 

No fee required.

Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.


Title of each class of securities to which transaction applies:


Aggregate number of securities to which transaction applies:

Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11


(set forth the amount on which the filing fee is calculated and state how it was determined):


Proposed maximum aggregate value of transaction:


Total fee paid:

Fee paid previously with preliminary materials.

Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.


Amount Previously Paid:


Form, Schedule or Registration Statement No.:


Filing Party:


Date Filed:

Your Vote Counts! APREA THERAPEUTICS, INC. 2021 Annual Meeting to be held on June 9, 2021 Vote by June 8, 2021 11:59 PM ET APREA THERAPEUTICS, INC. 535 BOYLSTON STREET BOSTON, MA 02116 D52037-P56905 You invested in APREA THERAPEUTICS, INC. and it’s time to vote! You have the right to vote on proposals being presented at the Annual Meeting. This is an important notice regarding the availability of proxy materials for the stockholder meeting to be held on June 9, 2021. Get informed before you vote View the Notice, Proxy Statement and 2020 Annual Report online OR you can receive a free paper or email copy of the materials by requesting prior to May 26, 2021. If you would like to request a copy of the materials for this and/or future stockholder meetings, you may (1) visit, (2) call 1-800-579-1639 or (3) send an email to If sending an email, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy. Smartphone users Point your camera here and vote without entering a control number Vote Virtually During the Meeting June 9, 2021 9:00 A.M. Eastern Time Virtually at: V1 For complete information and to vote, visit Control #

Vote at THIS IS NOT A VOTABLE BALLOT This is an overview of the proposals being presented at the upcoming stockholder meeting. Please follow the instructions on the reverse side to vote these important matters. Board Recommends Voting Items D52038-P56905 Prefer to receive an email instead? While voting on, be sure to click “Sign up for E-delivery”. 1. ELECTION OF TWO CLASS II DIRECTORS AND ONE CLASS I DIRECTOR 1a. Johan Christenson, M.D., Ph.D. (Class II) For 1b. Fouad Namouni, M.D. (Class II) For 1c. Richard Peters, M.D., Ph.D. (Class I) For 2. RATIFICATION OF APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR FISCAL YEAR 2021 For